Wed.Mar 26, 2025

article thumbnail

Opinion: The neurosurgeon keeping ‘Severance’ (relatively) medically accurate

STAT

On a recent Friday evening, it struck me: I needed to speak to a neurosurgeon. I was watching someone root around in actor Adam Scott’s head on an episode from the second season of “Severance” on Apple TV+. (Note: This post and podcast episode contain spoilers for “Severance.” You’ve been warned.) I needed to know: How realistic is the brain surgery that gives the show its name and premise?

209
209
article thumbnail

Rx-to-OTC rule gets pushed back — again

PharmaVoice

A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Make America Healthy Again is ringing through statehouses across the U.S.

STAT

You’re reading The MAHA Diagnosis , a STAT series that examines the major elements of the Make America Healthy Again movement led by Robert F. Kennedy Jr. From cancer warning labels to soda taxes , progressive states like California and New York have long led the way on legislation meant to improve public health. Now the Make America Healthy Again movement is prompting lawmakers in more conservative states, like Texas, Florida, Oklahoma, and Utah, to join blue ones in introducing bills th

Labelling 175
article thumbnail

Nouscom reveals promising results for lynch syndrome immunotherapy

Pharma Times

NOUS-209 shows potential to intercept cancer in its early stages

72
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

STAT+: Wave to submit Duchenne drug for approval after Phase 2 success

STAT

Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the stage for a new therapeutic option for patients with the rare disease.  Duchenne muscular dystrophy is a condition that primarily affects young boys, starving their bodies of dystrophin protein required for muscle function.

163
163

More Trending

article thumbnail

STAT+: Tara Schwetz, who oversaw creation of ARPA-H, placed on leave by NIH 

STAT

The National Institutes of Health on Wednesday placed deputy director Tara Schwetz on administrative leave, according to a source familiar with the decision, marking the third time a senior leader has departed the agency since the Trump administration took power roughly nine weeks ago.  Schwetz had served as deputy director for coordination, planning, and strategic initiatives, a position she has held since late 2023.

157
157
article thumbnail

Gary Lyons appointed as EVP medical affairs of Coronado Research

Pharmafile

Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for medical affairs. Lyons is a medical affairs leader, with experience in senior positions in pharmaceutical, consultancy and agency sectors. He has worked on developing medical communication services locally and globally.

59
article thumbnail

STAT+: This Canadian company’s AI tool could help drugmakers cut risk in late-stage cancer trials

STAT

When AstraZeneca announced the results of its failed lung cancer immunotherapy trial in 2017, its stock plunged 16%. But that data was good for something — today, the drugmaker presented a re-evaluation of data from that trial using an AI tool, which outperformed the conventional method of predicting overall survival in lung cancer patients. The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal cancer scans, potentially

article thumbnail

Cold Chain Technologies acquires Global Cold Chain Solutions

Pharmafile

Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), a provider of passive cold chain solutions primarily in Australia and India. Based in Massachusetts, US, the deal furthers CCT’s reach to South Asia and Oceania, where there is vast investment in life sciences verticals. […] The post Cold Chain Technologies acquires Global Cold Chain Solutions appeared first on Pharmafile.

59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Recent pharma-telehealth partnerships feel ‘black boxy,’ and why that’s problematic

STAT

In recent months, a new kind of partnership between telehealth companies and pharmaceutical manufacturers has come under scrutiny over concerns that such arrangements could lead to inappropriate prescriptions and poor care. Eli Lilly and Pfizer, along with five telehealth companies accessible through the pharma companies’ websites, have recently received letters from four senators echoing those concerns, asking questions about care, prescription volume, and the flow of data and money betw

article thumbnail

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID

Pharmafile

Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in common variable immunodeficiency (CVID) patients with immune dysregulation. The company, based in Leiden, the Netherlands, specialises in developing and commercialising medicines for patients with rare, debilitating and life threatening diseases.

59
article thumbnail

STAT+: Your questions answered: How insurers are using AI

STAT

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine.  Sign up to get it  delivered in your inbox every Wednesday.   My colleague Casey Ross has been reporting on AI in health care since before it was cool (remember IBM’s Watson ?

137
137
article thumbnail

Allegro shares promising preclinical results for osteoarthritis treatment

Pharmafile

Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is a biomedical company that develops nanotechnology-based treatments for degenerative joint disease. The preclinical studies were conducted in rats for periods of four and 13 weeks, respectively. Hydrocelin was injected into four separate locations, and a […] The post Allegro shares promising preclinical results for osteoarthritis treatment appeared

59
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The need-to-know on yesterday’s health leadership votes & noms

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! I hate to admit this as a TV lover, but I still haven’t seen “Severance.” I know, I know, it’s the best. I still enjoyed the conversation on the First Opinion Podcast between STAT editor Torie Bosch and Vijay Agarwal, the medical consultant on the series.

137
137
article thumbnail

Character raises $93m for eye drugs, plus other financings

pharmaphorum

Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines

59
article thumbnail

Trump administration says it will pull back billions in Covid funding from local health departments

STAT

Federal health officials said Tuesday they are pulling back $11.4 billion in COVID-19-related funds for state and local public health departments and other health organizations throughout the nation. “The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago,” the U.S.

130
130
article thumbnail

DKSH Technology Acquires Taqkey Science and Quantum Biotech, two technology distribution companies in Taiwan

Express Pharma

DKSH has announced that it signed an agreement to acquire Taqkey and Quantum, two life science reagent and consumables distribution companies in Taiwan. The distributed products encompass reagents and consumables for molecular biology, genetic engineering, and cell-based therapies. Thus, DKSH Technology further anchors its regional presence in the life science industry in Athe sia-Pacific.

59
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Altis says its AI tool can cut risk in cancer trials

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. The MAHA movement is influencing not only the federal government, but also state legislatures across the U.S. We discuss all that and the key biotech news today.

article thumbnail

Epicrispr banks $68M to test epigenetic editing on rare muscle disease

BioPharma Dive

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.

59
article thumbnail

AdjuTec Pharma, Venus Remedies initiate research collaboration to evaluate APC-148 against AMR

Express Pharma

AdjuTec Pharma AS, a privately held company developing antibiotic resistance breakers, announces that it has entered into a research collaboration agreement with Venus Remedies. Venus Remedies will perform a pre-clinical evaluation of AdjuTec Pharmas APC-148 platform technology. AdjuTec Pharma has developed novel inhibitor technologies that selectively destroy antibiotic resistance mechanisms in multidrug-resistant bacteria, thereby restoring the effectiveness of commercially available antibioti

59
article thumbnail

Pharmacy minister calls NPA action 'premature and unnecessary'

The Pharmacist

Pharmacy minister Stephen Kinnock has called the National Pharmacy Association (NPA)'s proposed collective action 'premature, unnecessary and detrimental to community pharmacy patients'. And he urged the NPA to 'reconsider its position' and wait for the outcome of funding negotiations with Community Pharmacy England (CPE). Mr Kinnock added that the negotiations had been 'constructive' and 'will […] The post Pharmacy minister calls NPA action 'premature and unnecessary' appeared f

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

DoP hosts industry dialogue on promotion of research and innovation in pharma-medtech sector scheme

Express Pharma

The Department of Pharmaceuticals, Government of India, hosted an Industry Dialogue on the scheme for the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) in Bangalore on 25th March 2025. The event served as a platform for representatives from industry, startups, and research institutes, including representatives from the Indian Council for Medical Research (ICMR), Council of Scientific and Industrial Research (CSIR), and innovation hubs like C-CAMP (Centre for Cellular a

59
article thumbnail

Could Trump force us to pay more for our medicines? - podcast

The Guardian - Pharmaceutical Industry

Big pharma is eyeing Australias Pharmaceutical Benefits Scheme, as they lobby Donald Trump to demand higher prices for their medicines. Anthony Albanese has promised to bring down the price of PBS-listed medicines to no more than $25 a script, while the Coalition has already pledged to match it if they return to government. Senior reporter Tory Shepherd speaks to Reged Ahmad about the politics of our affordable medicines You can support the Guardian at theguardian.com/fullstorysupport Read more:

52
article thumbnail

MHRA launches new monthly safety bulletins

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins aimed at making medical device and medicine safety information clearer and more accessible for healthcare professionals.

52
article thumbnail

Compliance Challenges in Generic Drug Development: Lessons Learned

Drug Patent Watch

The Unseen Hurdles of Generic Drug Development: Lessons Learned As the pharmaceutical industry continues to evolve, one thing remains constant: the pursuit of affordable, high-quality medications for patients worldwide. Generic drugs have long been a vital part of this equation, offering a more accessible alternative to brand-name medications. However, the journey to bringing a generic drug to market is often fraught with challenges.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.